Noumi Faces Convertible Notes Maturity and Market Variability Despite Strong Q1
Noumi Limited reported a 9.0% increase in revenue to $162.4 million for Q1 FY26, driven by strong growth in Dairy and Nutritionals and Milklab plant-based milks, while successfully closing legacy legal matters.
- Q1 FY26 revenue up 9.0% to $162.4 million
- Dairy and Nutritionals segment grows 13.7%
- Milklab plant-based milks sales increase 9.3%
- Operating cash flow positive at $12.8 million despite $3.7 million legal expenses
- Convertible notes maturity planning underway for 2027
Strong Revenue Growth Amid Market Variability
Noumi Limited, a prominent Australian FMCG company specialising in dairy and plant-based milks, has kicked off FY26 with a solid financial performance. The company reported consolidated revenue of $162.4 million for the quarter ended 30 September 2025, marking a 9.0% increase compared to the same period last year. This growth was primarily driven by a 13.7% surge in the Dairy and Nutritionals segment and a 9.3% rise in Milklab plant-based milk sales.
While overall Plant-based Milks revenue dipped slightly by 1.0%, this was largely due to lower contract manufacturing revenues. Notably, Milklab’s oat milk product saw a remarkable 29.7% revenue increase, supported by a 3.8% uplift in almond milk sales. The HORECA (hotel, restaurant, and café) channel also contributed positively, with a 4.7% revenue growth in plant-based milks and a 13.0% increase in dairy long-life domestic sales.
Resolving Legacy Legal Matters and Cash Flow Strength
Noumi’s operating cash flow was a healthy $12.8 million for the quarter, despite absorbing $3.7 million in legal expenses related to closing out legacy matters. These legal issues were fully provided for in the previous fiscal year and were resolved following Victorian Supreme Court approval of a class action settlement in September 2025. The company also benefited from $1.7 million in proceeds from the release of a term deposit tied to US litigation obligations.
At quarter-end, Noumi held $21.9 million in unrestricted cash and maintained $10 million in undrawn credit facilities, providing a combined liquidity buffer of $31.9 million. Capital expenditure was modest at $1.1 million, focused on property, plant, and equipment, while lease repayments and convertible note interest payments were also made during the period.
Convertible Notes and Future Outlook
Looking ahead, Noumi has begun planning for the maturity of its $597.4 million convertible notes due in 2027. These notes are carried at fair value on the balance sheet and are expected to increase to a minimum redemption value of $610.4 million by maturity, assuming ongoing cash interest payments at 4% per annum. The company’s financing facilities remain robust, with primary banking relationships through HSBC Bank Australia and National Australia Bank.
Despite the encouraging start to FY26, Noumi acknowledges variability in month-to-month market conditions. The company remains cautiously optimistic but is focused on maintaining momentum across its key product segments while managing financial obligations prudently.
Bottom Line?
Noumi’s strong start to FY26 and resolution of legacy legal issues set the stage for navigating upcoming financial milestones and market challenges.
Questions in the middle?
- How will Noumi manage the upcoming $610 million convertible notes maturity in 2027?
- What impact will market variability have on plant-based milk growth in coming quarters?
- Can Noumi sustain its momentum in Dairy and Nutritionals amid evolving consumer trends?